Study Summary
This trial will test whether embolization done prior to surgery will improve surgical outcomes in head and neck tumors with large amounts of blood vessels.
- Head and Neck Cancer
Treatment Effectiveness
Effectiveness Progress
Study Objectives
1 Primary · 4 Secondary · Reporting Duration: Intraoperatively
Trial Safety
Safety Progress
Trial Design
1 Treatment Group
Treatment (PVA, EOV, tumor vessel embolization)
1 of 1
Experimental Treatment
20 Total Participants · 1 Treatment Group
Primary Treatment: Angiogram · No Placebo Group · Phase 1
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18 - 80 · All Participants · 13 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Frequently Asked Questions
What are the requirements to take part in this research experiment?
"This clinical trial seeks 20 participants with malignant neoplasms aged between 18 and 80. To be eligible, they must have a blood supply from the external carotid artery, intend to undertake surgical resection of their tumors, meet imaging requirements through MRI or CT scans, may have prior therapies under their belt; adults within the specified age range are also required with a minimum life expectancy period of 3 months. Moreover, applicants need an eGFR above 30 mL/min/1.73 m^2 not being pregnant at angiographic intervention and having extra-axial head & neck tumours greater than 2 cm in size." - Anonymous Online Contributor
Does this medical trial admit seniors over the age of 65?
"This trial only allows people aged 18 to 80, with 315 studies catering towards minors and 2,553 targeting patients over the age of 65." - Anonymous Online Contributor
What is the maximum capacity of participants enrolled in this research?
"Affirmative. The information listed on clinicaltrials.gov discloses that this research is actively searching for participants who meet the eligibility criteria. This trial was initially posted in December 1, 2022 and recently updated in November 4, 2022; a total of 20 patients are needed from one medical center to participate." - Anonymous Online Contributor
Is this clinical trial open to new participants at the moment?
"Affirmative. Clinicaltrials.gov's records demonstrate that this clinical trial, which was initially made available on December 1st 2022, is currently recruiting participants. The study requires 20 patients to be recruited from only one medical centre." - Anonymous Online Contributor
Has Angiogram been endorsed by the FDA?
"This experimental drug has been assigned a rating of 1, as there is only limited evidence regarding its safety and effectiveness." - Anonymous Online Contributor